fluorescein novartis
novartis pharmaceuticals australia pty ltd - fluorescein sodium -
minims fluorescein sodium
bausch & lomb uk limited - fluorescein sodium - eye drops solution - 1 %w/v - fluorescein
minims fluorescein sodium
bausch & lomb uk limited - fluorescein sodium - eye drops solution - 2.0 %w/v - fluorescein
dry eye test- fluorescein sodium strip
nomax inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - fluorescein 0.12 mg - for testing tear film stability by determining the fluorescein break-up time (fbut). hypersensitivity to components or mercury-containing compounds.
fluorescein sodium and benoxinate hydrochloride solution/ drops
bausch & lomb incorporated - benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303), fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - benoxinate hydrochloride 4 mg in 1 ml - for procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product. prolonged use of a topical ocular anesthetic is not recommended. it may produce permanent corneal opacification with accompanying visual loss.
flurox (fluorescein sodium 2.5mg (0.25%), benoxinate hydrochloride 4mg- 0.4% solution
ocusoft, inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - flourescein sodium and benoxinate hydrochloride opthalmic solution usp, 0.25%/0.4% is a disclosing agent with rapid anesthetic action of short duration. fluorescein sodium is represented by the following structural formula: chemical name: spiro [isobenzofuran-1 (3h ),9'-[9h ] xanthene]-3-one, 3',6' dihydroxy, disodium salt. benoxinate hydrochloride is represented by the following structural formula: chemical name: 2-(diethylamino) ethyl 4-amino-3butoxybenzoate monohydrochloride. for procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product.
odan-fluorescein solution
odan laboratories ltd - fluorescein sodium - solution - 100mg - fluorescein sodium 100mg - other diagnostic agents
odan-fluorescein liquid
odan laboratories ltd - fluorescein sodium - liquid - 250mg - fluorescein sodium 250mg - other diagnostic agents
minims lidocaine (lignocaine) 4% and fluorescein 0.25% eye drops tube
bausch & lomb australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 40 mg/ml; fluorescein sodium, quantity: 2.5 mg/ml - eye drops, solution - excipient ingredients: purified water; hydrochloric acid; povidone - as a diagnostic stain and topical anaesthetic combined, minims lignocaine and fluorescein is intended primarily to facilitate goldmann applanation tonometry.
fluorescein serb 100mgml solution for injection
zuellig pharma pte. ltd. - fluorescein sodium - injection, solution - 0.5g/5ml - fluorescein sodium 0.5g/5ml